Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders

PR Newswire
June 1, 2023 — 08:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Australia Beijing biotech Covid-19 healthcare medicine Pandemic Racism Shanghai technology

Related News:

The 9th Asian Winter Games takes place

February 8, 2025 — 19:58

Dubai Fountain Undergoes a Stunning Revamp: Temporary Closure Announced for Upgrade and Enhancement

February 6, 2025 — 00:29

Dubai Fountain Undergoes a Stunning Revamp: Temporary Closure Announced for Upgrade and Enhancement

February 6, 2025 — 00:21

Star-Studded Sponsor Line-up Takes Centre Court at the Singapore Tennis Open 2025

January 28, 2025 — 10:49

Trip.com Group champions further recovery and long-term growth for ASEAN tourism

January 27, 2025 — 15:43

Empowering Women Worldwide through Technology: #TCLforHer Wins the Prestigious Telly Award and Multiple International Marketing Honors

January 25, 2025 — 17:35

Altair Engineering Inc. Stockholders Approve Proposed Merger with Siemens

January 23, 2025 — 05:05

BICV’s Debut at CES 2025: Showcasing Full-Stack, All-Domain Products on the International Stage

January 9, 2025 — 22:03

MANTRA and DAMAC Group Revolutionize Tokenized Real-World Assets with US$1 Billion Deal

January 9, 2025 — 22:00

Franchising and Licensing Asia (FLAsia) 2024